Filing Details

Accession Number:
0001012975-15-000074
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-30 14:15:55
Reporting Period:
2015-01-28
Filing Date:
2015-01-30
Accepted Time:
2015-01-30 14:15:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1454189 Auspex Pharmaceuticals Inc. ASPX Pharmaceutical Preparations (2834) 954862842
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1512058 Alex Zisson 45 South Seventh Street
Suite 3060
Minneapolis MN 55402
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-01-28 730,000 $53.11 4,835,731 No 4 S Indirect see footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect see footnote
Footnotes
  1. The securities were sold to the underwriter by the Reporting Persons in connection with a secondary offering of the Issuer's securities as follows: 719,780 shares by Thomas, McNerney & Partners II, L.P. ("TMP II"), 7,519 shares by TMP Nominee II, LLC ("TMPN II") and 2,701shares by TMP Associates II, L.P. ("TMPA II").
  2. Includes 4,768,041 shares held in the name of TMP II; 49,805 shares held in the name of TMPN II; and 17,885 shares held in the name of TMPA II.
  3. The securities are held in the name of TMP II, TMPN II and TMPA II. Thomas, McNerney & Partners II, LLC ("TMP II LLC") is the general partner of TMP II and TMPA II. Alex Zisson is a manager of TMP II LLC and has shared voting and dispositive power over the securities held by TMP II and TMPA II, but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.